As of 2025-09-17, the EV/EBITDA ratio of Reata Pharmaceuticals Inc (RETA) is -15.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RETA's latest enterprise value is 5,813.45 mil USD. RETA's TTM EBITDA according to its financial statements is -378.12 mil USD. Dividing these 2 quantities gives us the above RETA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 15.3x | 11.6x |
| Forward P/E multiples | 12.1x - 15.9x | 14.6x |
| Fair Price | (137.17) - (172.97) | (148.20) |
| Upside | -179.6% - -200.4% | -186.0% |
| Date | EV/EBITDA |